Bicara Therapeutics Inc.'s market cap is currently $756.79M. The company's EPS TTM is $-0.5; its P/E ratio is ―; Bicara Therapeutics Inc. is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Currency in USD
Bicara Therapeutics Inc. Earnings and Revenue History
